Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's Sunscreen Progress Gets Dim Review From Congressional Appropriators

Aug 07 2018

• By Malcolm Spicer

Capitol House

Related Content

Spray Sunscreens Stay In FDA Enforcement Discretion Shade

May 23 2018

Spray Sunscreens Stay In FDA Enforcement Discretion Shade

May 23 2018

FDA’s MUsT Draft Guidance Extends Challenge To Wider OTC Drug Industry

May 23 2018

House Passes US OTC Monograph Reform And Committee Clears HSA Change

Jul 18 2018

Gottlieb Showing Capitol Hill Skills With Funding Success

Mar 24 2018

FDA Could Stick With Current Advice On NDI Notifications, Old Ingredient Evidence

Jun 26 2018

FSMA Re-inspection Fees MIA As Waiver Guidance Remains AWOL

Aug 02 2017

Additional Topics

United States Legislation Drug Approval Standards OTC Drugs Cosmetics Cancer Consumer Dermatology

More from Legislation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window